NCT03711695 is a clinical trial of iBeat wristwatch device in Arrythmia, Cardiac, sponsored by University of California, San Francisco.

Who is sponsoring NCT03711695?

NCT03711695 is sponsored by University of California, San Francisco.

What drugs are being tested in NCT03711695?

Interventions in NCT03711695: iBeat wristwatch device.

What condition does NCT03711695 study?

NCT03711695 studies Arrythmia, Cardiac.

Is NCT03711695 still recruiting?

NCT03711695 is currently completed. Last updated 5 March 2019.

Last reviewed 2019-03-05 · How we verify

NCT03711695

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

iBeat Wristwatch Validation Study

Completed Last updated 5 March 2019

What this trial tests

trial testing iBeat wristwatch device in Arrythmia, Cardiac in 55 participants. Completed in 30 December 2018.

Timeline

22 March 2018

Primary endpoint
30 December 2018

30 December 2018

Quick facts

Lead sponsor	University of California, San Francisco
Status	Completed
Study type	OBSERVATIONAL
Enrollment	55
Start date	22 March 2018
Primary completion	30 December 2018
Estimated completion	30 December 2018
Sites	1 location across United States

Drugs / interventions tested

iBeat wristwatch device

Conditions studied

Arrythmia, Cardiac — all drugs for Arrythmia, Cardiac →

Sponsor

University of California, San Francisco

Who can join

Adults 21 to 85, any sex, with Arrythmia, Cardiac. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The iBeat Study is a single-center, prospective, unblinded validation of the photoplethysmography (PPG) and tissue oximetry (TO) signal waveforms recorded from a wrist-based sensor devices.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Arrythmia, Cardiac

Currently open trials in the same condition.

NCT04036695 — Arrhythmia in Hemodialysis Patients · NA · active not recruiting

Other University of California, San Francisco trials

Trials by the same sponsor.

NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03711695 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 5 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03711695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing